FI915826L - Farmaceutiska aemnen. - Google Patents

Farmaceutiska aemnen. Download PDF

Info

Publication number: FI915826L
Authority: FI; Finland
Prior art keywords: aemnen; pharmaceutical; pharmaceutical aemnen
Prior art date: 1990-12-12

Application number

FI915826A

Other languages

English (en)

Other versions

FI101193B1 (fi

FI915826A0 (fi

FI101193B (fi

Inventor

James Joseph Holohan

Ieuan John Edwards

Robert Joseph Timko

Randy John Bradway

Arlene Clements

Original Assignee

Ici Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-12

Filing date

1991-12-11

Publication date

1992-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26298105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI915826(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-12-12 Priority claimed from GB909027014A external-priority patent/GB9027014D0/en

1991-07-12 Priority claimed from GB919115107A external-priority patent/GB9115107D0/en

1991-12-11 Application filed by Ici Plc filed Critical Ici Plc

1991-12-11 Priority to FI980376A priority Critical patent/FI980376A0/fi

1991-12-11 Publication of FI915826A0 publication Critical patent/FI915826A0/fi

1992-03-31 Publication of FI915826L publication Critical patent/FI915826L/fi

1997-06-13 Priority to FI972528A priority patent/FI106021B/fi

1998-05-15 Application granted granted Critical

1998-05-15 Publication of FI101193B1 publication Critical patent/FI101193B1/fi

1998-05-15 Publication of FI101193B publication Critical patent/FI101193B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Inorganic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Dermatology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

FI915826A 1990-12-12 1991-12-11 Menetelmä N-£4-£5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3 -yyli-metyyli|-3-metoksibentsoyyli|-2-metyylibentseenisulfonamidin fys ikaalista muotoa sisältävän farmaseuttisen koostumuksen valmistamiseks i FI101193B (fi)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
FI980376A FI980376A0 (fi)	1990-12-12	1991-12-11	N-/4-/5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli/-3-metoksibentsoyyli/-2-metyylibentseenisulfonamidin fysikaalista muotoa sisältävä farmaseuttinen koostumus
FI972528A FI106021B (fi)	1990-12-12	1997-06-13	Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB909027014A GB9027014D0 (en)	1990-12-12	1990-12-12	Pharmaceutical agents
GB919115107A GB9115107D0 (en)	1991-07-12	1991-07-12	Pharmaceutical agents

Publications (4)

Publication Number	Publication Date
FI915826A0 FI915826A0 (fi)	1991-12-11
FI915826L true FI915826L (fi)	1992-03-31
FI101193B1 FI101193B1 (fi)	1998-05-15
FI101193B FI101193B (fi)	1998-05-15

Family

ID=26298105

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI915826A FI101193B (fi)	1990-12-12	1991-12-11	Menetelmä N-£4-£5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3 -yyli-metyyli\|-3-metoksibentsoyyli\|-2-metyylibentseenisulfonamidin fys ikaalista muotoa sisältävän farmaseuttisen koostumuksen valmistamiseks i

Country Status (30)

Country	Link
US (6)	US5319097A (fi)
EP (1)	EP0490648B1 (fi)
JP (1)	JP2585495B2 (fi)
KR (2)	KR0183027B1 (fi)
CN (2)	CN1043405C (fi)
AP (1)	AP285A (fi)
AT (1)	ATE131048T1 (fi)
AU (1)	AU656157B2 (fi)
BE (1)	BE1004229A5 (fi)
CA (2)	CA2056066C (fi)
CZ (1)	CZ283181B6 (fi)
DE (2)	DE69115229T2 (fi)
DK (1)	DK0490648T3 (fi)
ES (1)	ES2079589T3 (fi)
FI (1)	FI101193B (fi)
FR (1)	FR2670488B1 (fi)
GB (2)	GB2251791B (fi)
GR (1)	GR3018318T3 (fi)
HK (2)	HK81397A (fi)
HU (2)	HU213211B (fi)
IE (1)	IE75348B1 (fi)
IL (1)	IL100091A (fi)
IT (1)	IT1256282B (fi)
MX (1)	MX9102473A (fi)
MY (1)	MY106315A (fi)
NZ (1)	NZ240939A (fi)
PH (1)	PH30928A (fi)
RU (1)	RU2106140C1 (fi)
SK (2)	SK279813B6 (fi)
TW (1)	TW276181B (fi)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL100091A (en) *	1990-12-12	1998-08-16	Zeneca Ltd	Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
GB9119001D0 (en) *	1991-09-05	1991-10-23	Ici Plc	Pharmaceutical agents
GR1001368B (el) *	1992-10-08	1993-10-29	Ici Plc	Φαρμακευτικοί φορείς.
DE4235133A1 (de) *	1992-10-19	1994-04-21	Bayer Ag	Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
DE9410461U1 (de) *	1994-07-01	1994-09-22	Merck Patent Gmbh, 64293 Darmstadt	Mittel für die Röntgenfluoreszenzanalyse
US6279736B1 (en)	1995-04-19	2001-08-28	Capitol Specialty Plastics, Inc.	Barrier pack having an absorbing agent applied to the interior of the pack
IN182496B (fi) *	1996-02-20	1999-04-17	Reddy Research Foundation
US6630496B1 (en)	1996-08-26	2003-10-07	Genetics Institute Llc	Inhibitors of phospholipase enzymes
USRE43932E1 (en)	1997-07-18	2013-01-15	Novartis Ag	Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
GB9723985D0 (en) *	1997-11-14	1998-01-14	Zeneca Ltd	Pharmaceutical compositions
GB9726735D0 (en) *	1997-12-18	1998-02-18	Zeneca Ltd	Pharmaceutical compositions
US6916841B2 (en) *	1998-02-25	2005-07-12	Genetics Institute, Llc	Inhibitors of phospholipase enzymes
US6828344B1 (en)	1998-02-25	2004-12-07	Genetics Institute, Llc	Inhibitors of phospholipase enzymes
US6500853B1 (en)	1998-02-28	2002-12-31	Genetics Institute, Llc	Inhibitors of phospholipase enzymes
US6224907B1 (en) *	1998-03-06	2001-05-01	Alza Corporation	Anti-asthma therapy
KR100283682B1 (ko) *	1998-07-14	2001-03-02	조정래	열풍건조장치
US6253463B1 (en)	1999-04-26	2001-07-03	Niro A/S	Method of spray drying
IN191496B (fi)	1999-07-30	2003-12-06	Ranbaxy Lab Ltd
EP1216058A2 (en) *	1999-09-20	2002-06-26	Alza Corporation	Process for lessening polymorphic conversion of a drug
DE10006139A1 (de) *	2000-02-11	2001-08-16	Merck Patent Gmbh	Indol-3-yl-Derivate
IL139243A0 (en) *	2000-10-24	2001-11-25	Internat Specialty Products Is	Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
IL140096A0 (en) *	2000-12-05	2002-02-10	Internat Specialty Products Is	Process for preparation of zafirlukast
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US20060287254A1 (en) *	2001-01-26	2006-12-21	Schering Corporation	Use of substituted azetidinone compounds for the treatment of sitosterolemia
ATE331512T1 (de)	2001-01-26	2006-07-15	Schering Corp	Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
MEP27808A (en) *	2001-01-26	2010-10-10	Schering Corp	Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
CA2453182A1 (en) *	2001-07-10	2003-01-23	Meredith L. Greene	Crystalline thiazine oxazolidinones
CA2455050C (en) *	2001-08-15	2007-02-20	Pharmacia & Upjohn Company	Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
JP2005504091A (ja)	2001-09-21	2005-02-10	シェーリング　コーポレイション	ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7053080B2 (en) *	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
AR040588A1 (es) *	2002-07-26	2005-04-13	Schering Corp	Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
WO2004043457A1 (en)	2002-11-06	2004-05-27	Schering Corporation	Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US7459442B2 (en) *	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
MXPA05009501A (es) *	2003-03-07	2005-10-18	Schering Corp	Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
CA2517571C (en) *	2003-03-07	2011-07-05	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1606287B1 (en)	2003-03-07	2013-10-02	Merck Sharp & Dohme Corp.	Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US20090317476A1 (en) *	2003-07-31	2009-12-24	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113410A1 (en) *	2003-11-03	2005-05-26	Mark Tawa	Pharmaceutical salts of zafirlukast
MY142017A (en) *	2004-03-19	2010-08-16	Nestec Sa	Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
ITMI20041032A1 (it) *	2004-05-24	2004-08-24	Neuroscienze S C A R L	Compositi farmaceutici
EP1855651A4 (en) *	2005-03-03	2011-06-15	Elan Pharma Int Ltd	NANOPARTICLE COMPOSITIONS OF HETEROCYCLIC AMID DERIVATIVES
US20070197467A1 (en) *	2006-02-06	2007-08-23	Srinivasulu Rangineni	Zafirlukast compositions
US20090012146A1 (en) *	2007-07-02	2009-01-08	Giridhar Reddy Buggana	Solubility-enhanced pharmaceutical compositions comprising zafirlukast
JP2010535234A (ja) *	2007-07-30	2010-11-18	オースペックス・ファーマシューティカルズ・インコーポレイテッド	置換インドール
US20090149662A1 (en) *	2007-12-05	2009-06-11	Raghupathi Reddy Anumula	Processes for preparing zafirlukast
WO2014012954A1 (en)	2012-07-18	2014-01-23	Takeda Gmbh	Treatment of partly controlled or uncontrolled severe asthma
WO2015110394A1 (en)	2014-01-22	2015-07-30	Takeda Gmbh	Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier)
PT109030B (pt) *	2015-12-15	2019-09-25	Hovione Farmaciência, S.A.	Preparação de partículas inaláveis de zafirlucaste
BR112019015721A2 (pt)	2017-01-30	2020-03-24	Western New England University	Inibidores de tiol isomerases e uso dos mesmos
US10752585B2 (en)	2017-12-28	2020-08-25	Council Of Scientific & Industrial Research	Process for the preparation of Zafirlukast and analogs thereof
US12403122B2 (en)	2021-05-19	2025-09-02	Quercis Pharma AG	Method for treating amyotrophic lateral sclerosis using quercetin-containing compositions
WO2023214391A1 (en)	2022-05-06	2023-11-09	Quercis Pharma AG	Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8607294D0 (en) *	1985-04-17	1986-04-30	Ici America Inc	Heterocyclic amide derivatives
IL100091A (en) *	1990-12-12	1998-08-16	Zeneca Ltd	Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
GB9027018D0 (en) *	1990-12-12	1991-01-30	Ici Plc	Heterocyclic compounds

1991
- 1991-11-19 IL IL10009191A patent/IL100091A/en not_active IP Right Cessation
- 1991-11-22 CA CA002056066A patent/CA2056066C/en not_active Expired - Lifetime
- 1991-11-22 CA CA002319308A patent/CA2319308C/en not_active Expired - Lifetime
- 1991-12-09 HU HU913865A patent/HU213211B/hu unknown
- 1991-12-10 TW TW080109698A patent/TW276181B/zh not_active IP Right Cessation
- 1991-12-10 MX MX9102473A patent/MX9102473A/es unknown
- 1991-12-11 BE BE9101127A patent/BE1004229A5/fr not_active IP Right Cessation
- 1991-12-11 AU AU88994/91A patent/AU656157B2/en not_active Expired
- 1991-12-11 EP EP91311504A patent/EP0490648B1/en not_active Expired - Lifetime
- 1991-12-11 DK DK91311504.4T patent/DK0490648T3/da active
- 1991-12-11 GB GB9126354A patent/GB2251791B/en not_active Expired - Lifetime
- 1991-12-11 DE DE69115229T patent/DE69115229T2/de not_active Expired - Lifetime
- 1991-12-11 US US07/805,421 patent/US5319097A/en not_active Expired - Lifetime
- 1991-12-11 AP APAP/P/1991/000340A patent/AP285A/en active
- 1991-12-11 KR KR1019910022917A patent/KR0183027B1/ko not_active Expired - Lifetime
- 1991-12-11 DE DE4140858A patent/DE4140858A1/de not_active Withdrawn
- 1991-12-11 PH PH43619A patent/PH30928A/en unknown
- 1991-12-11 MY MYPI91002302A patent/MY106315A/en unknown
- 1991-12-11 AT AT91311504T patent/ATE131048T1/de not_active IP Right Cessation
- 1991-12-11 IT ITMI913324A patent/IT1256282B/it active IP Right Grant
- 1991-12-11 FR FR9115366A patent/FR2670488B1/fr not_active Expired - Fee Related
- 1991-12-11 NZ NZ240939A patent/NZ240939A/en not_active IP Right Cessation
- 1991-12-11 FI FI915826A patent/FI101193B/fi not_active IP Right Cessation
- 1991-12-11 CZ CS913756A patent/CZ283181B6/cs not_active IP Right Cessation
- 1991-12-11 SK SK3756-91A patent/SK279813B6/sk not_active IP Right Cessation
- 1991-12-11 RU SU5010340/14A patent/RU2106140C1/ru active
- 1991-12-11 JP JP3327783A patent/JP2585495B2/ja not_active Expired - Fee Related
- 1991-12-11 IE IE431091A patent/IE75348B1/en not_active IP Right Cessation
- 1991-12-11 ES ES91311504T patent/ES2079589T3/es not_active Expired - Lifetime
- 1991-12-11 GB GB9418154A patent/GB2280606B/en not_active Expired - Lifetime
- 1991-12-11 CN CN91111566A patent/CN1043405C/zh not_active Expired - Lifetime
1993
- 1993-09-03 US US08/116,781 patent/US5482963A/en not_active Expired - Lifetime
1995
- 1995-03-13 US US08/403,132 patent/US5504216A/en not_active Expired - Lifetime
- 1995-06-07 US US08/474,191 patent/US5612367A/en not_active Expired - Lifetime
- 1995-06-09 HU HU95P/P00181P patent/HU211126A9/hu unknown
- 1995-12-07 GR GR950403190T patent/GR3018318T3/el unknown
1996
- 1996-08-30 KR KR1019960036692A patent/KR100207802B1/ko not_active Expired - Lifetime
1997
- 1997-06-19 HK HK81397A patent/HK81397A/xx not_active IP Right Cessation
- 1997-06-19 HK HK81597A patent/HK81597A/xx not_active IP Right Cessation
1998
- 1998-05-20 SK SK664-98A patent/SK279814B6/sk not_active IP Right Cessation
- 1998-07-13 US US09/114,225 patent/US5993859A/en not_active Expired - Lifetime
- 1998-10-14 CN CN98121369A patent/CN1105705C/zh not_active Expired - Lifetime
1999
- 1999-11-23 US US09/447,414 patent/US6143775A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2056066A1 (en)	1992-06-13
CA2056066C (en)	2002-04-02
ATE131048T1 (de)	1995-12-15
FI101193B1 (fi)	1998-05-15
IT1256282B (it)	1995-11-29
JPH04266824A (ja)	1992-09-22
AP9100340A0 (en)	1992-01-31
IL100091A (en)	1998-08-16
CZ283181B6 (cs)	1998-01-14
JP2585495B2 (ja)	1997-02-26
ES2079589T3 (es)	1996-01-16
IE914310A1 (en)	1992-06-17
IE75348B1 (en)	1997-08-27
DE69115229T2 (de)	1996-05-09
HK81397A (en)	1997-06-27
NZ240939A (en)	1994-05-26
CN1043405C (zh)	1999-05-19
US5612367A (en)	1997-03-18
HU913865D0 (en)	1992-02-28
ITMI913324A0 (it)	1991-12-11
MX9102473A (es)	1992-06-01
ITMI913324A1 (it)	1993-06-11
US5993859A (en)	1999-11-30
KR920011493A (ko)	1992-07-24
CA2319308A1 (en)	1992-06-13
US6143775A (en)	2000-11-07
KR970005014A (ko)	1997-01-29
US5482963A (en)	1996-01-09
GB9126354D0 (en)	1992-02-12
AP285A (en)	1993-09-23
FI915826A0 (fi)	1991-12-11
GB2251791A (en)	1992-07-22
GB2251791B (en)	1995-05-17
IL100091A0 (en)	1992-08-18
HU213211B (en)	1997-03-28
GB9418154D0 (en)	1994-10-26
GB2280606A (en)	1995-02-08
FI101193B (fi)	1998-05-15
EP0490648B1 (en)	1995-12-06
AU656157B2 (en)	1995-01-27
TW276181B (fi)	1996-05-21
EP0490648A1 (en)	1992-06-17
FR2670488B1 (fr)	1994-01-28
CA2319308C (en)	2001-08-21
FR2670488A1 (fr)	1992-06-19
DE69115229D1 (de)	1996-01-18
HUT61281A (en)	1992-12-28
CS375691A3 (en)	1992-06-17
US5504216A (en)	1996-04-02
DK0490648T3 (da)	1996-05-06
CN1105705C (zh)	2003-04-16
HU211126A9 (en)	1995-10-30
CN1243827A (zh)	2000-02-09
HK81597A (en)	1997-06-27
SK279814B6 (sk)	1999-04-13
KR0183027B1 (ko)	1999-05-01
DE4140858A1 (de)	1992-06-17
CN1062291A (zh)	1992-07-01
MY106315A (en)	1995-04-29
GR3018318T3 (en)	1996-03-31
KR100207802B1 (ko)	1999-07-15
BE1004229A5 (fr)	1992-10-13
RU2106140C1 (ru)	1998-03-10
US5319097A (en)	1994-06-07
SK279813B6 (sk)	1999-04-13
PH30928A (en)	1997-12-23
GB2280606B (en)	1995-05-17
AU8899491A (en)	1992-06-18

Publication	Publication Date	Title
FI915826L (fi)	1992-03-31	Farmaceutiska aemnen.
FI914607L (fi)	1992-04-05	Farmaceutisk blandning i gelform i en dispenserfoerpackning.
FI922958A0 (fi)	1992-06-25	Farmaceutisk sammansaettning.
FI921060A0 (fi)	1992-03-11	Farmaceutiska aerosolformuleringar.
FI922316A0 (fi)	1992-05-21	Farmaceutisk sammansaettning.
FI922252A0 (fi)	1992-05-18	Farmaceutisk sammansaettning.
NO912799L (no)	1992-01-21	Foradditiver for droevtyggere.
FI911986L (fi)	1991-10-26	Farmaceutiska foereningar.
FI923581A0 (fi)	1992-08-11	Farmaceutisk kombinationsformation.
DE69112037D1 (de)	1995-09-14	Waferträger.
DE69111876D1 (de)	1995-09-14	Ophthalmometer.
FI86244B (fi)	1992-04-30	Bakugn-spisugnkombination.
FI86263B (fi)	1992-04-30	Skaer- och slipanordning foer en glasskivkant.
DE59104521D1 (de)	1995-03-16	Polkern.
FI87009B (fi)	1992-07-31	Skovelhjul foer centrifugalpumpar.
FI912061A0 (fi)	1991-04-29	Hoegspaennings stabiliseringskrets foer videodisplayanordning.
DE69100071D1 (de)	1993-06-09	Kaefigmutter.
FI913639A7 (fi)	1992-02-01	Farmaceutiska kompositioner.
FI914169L (fi)	1992-03-13	Elektronisk vattenregleranordning foer isframstaellningsmaskiner.
FI923371A0 (fi)	1992-07-24	En farmaceutisk formulation.
ATE124392T1 (de)	1995-07-15	8-sulfamylmethylen-2-aminotetraline.
FI920461A0 (fi)	1992-02-03	Oegondroppar.
FI900028A0 (fi)	1990-01-03	Belaeggningsmaterial.
DE59103525D1 (de)	1994-12-22	Honmachine.
DE69104797D1 (de)	1994-12-01	2-Substituierte-1-Hydroxyindole.

Legal Events

Date	Code	Title	Description
1994-03-23	GB	Transfer or assigment of application	Owner name: ZENECA LIMITED
2011-12-22	MA	Patent expired